Osman Faruk Senyuz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Osman Faruk Senyuz has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Sinan Celayir
Istanbul University
2 shared publications A. C. Celayir
Department of Pediatric Surgery, Cerrahpaşa Medical Faculty, Istanbul University, Istanbul, Turkey
1 shared publication- Akira Matsui
Department of Gastroenterology, Toranomon Hospital, Tokyo, Japan
1 shared publication - Ali Ekber Hakalmaz
Department of Pediatric Surgery, İstanbul University-Cerrahpaşa, Cerrahpaşa Faculty of Medicine, İstanbul, Turkey
1 shared publication - Ayse Kalyoncu Ucar
Department of Pediatric Radiology Istanbul University‐Cerrahpasa, Cerrahpasa Faculty of Medicine Istanbul Turkiye
1 shared publication - Buse Karakurt
Department of Pediatric Surgery, İstanbul University-Cerrahpaşa, Cerrahpaşa Faculty of Medicine, İstanbul, Turkey
1 shared publication
Latest Publications
- Open Access
- 2 July 2025
- Published by Springer Nature in BMC Pediatrics
- Vol. 25 (1) , 1-11
Three decades of progress: evolution of outcomes and prognostic indicators in biliary atresia management
Background: Biliary atresia (BA) remains a challenging condition with variable outcomes following Kasai portoenterostomy (KPE). This study evaluates the predictive value of three scoring systems (ALBI, APRI, and METAVIR) for prognostication and analyzes three decades of treatment outcomes at a single institution. Methods: Records of 96 BA patients who underwent KPE between 1990 and 2022 were retrospectively analyzed. Patients were stratified by preoperative ALBI (originally developed for HCC but applied here for its objective assessment of liver function), preoperative and postoperative APRI, and METAVIR scores. Treatment eras were divided into 1990–2000 (n = 18), 2001–2010 (n = 31), and 2011–2022 (n = 47). Clearance of jaundice was assessed at three months post-KPE, following established literature benchmarks. Kaplan-Meier curves and Log-Rank tests were used for survival analyses with a median follow-up of 5.1 years (range: 1–10 years). Results: The 10-year native liver survival (NLS) rate was 52.4%, with overall survival (OS) of 69.6%. Preoperative ALBI and APRI scores showed limited prognostic value (p = 0.12 and p = 0.17, respectively). However, postoperative APRI scores exceeding 1.12 at three months significantly predicted poor outcomes (p = 0.00094). METAVIR scores demonstrated poor correlation with long-term outcomes (p = 0.26). Analysis across treatment eras revealed significant improvement, with NLS increasing from 42.1 to 64.8% (p = 0.0029) and OS from 56.3 to 85.2% (p < 0.0001) between 1990 and 2000 and 2011–2022. Among the 52 patients with completed 10-year follow-up, the jaundice clearance rate at three months was 31.2%. Conclusions: While preoperative scoring systems showed limited predictive ability, postoperative APRI scores at three months emerged as a powerful predictor of long-term outcomes in BA patients. Our findings suggest that patients with three-month postoperative APRI scores > 1.12 should receive more intensive monitoring and earlier consideration for transplantation. The significant improvement in outcomes across three decades demonstrates the value of accumulated institutional experience and improved clinical management protocols in this challenging disease. Trial registration: Not applicable.
- 2 July 2025
- Published by Springer Nature in BMC Pediatrics
- Vol. 25 (1) , 1-11
Open AccessThree decades of progress: evolution of outcomes and prognostic indicators in biliary atresia management
Background: Biliary atresia (BA) remains a challenging condition with variable outcomes following Kasai portoenterostomy (KPE). This study evaluates the predictive value of three scoring systems (ALBI, APRI, and METAVIR) for prognostication and analyzes three decades of treatment outcomes at a single institution. Methods: Records of 96 BA patients who underwent KPE between 1990 and 2022 were retrospectively analyzed. Patients were stratified by preoperative ALBI (originally developed for HCC but applied here for its objective assessment of liver function), preoperative and postoperative APRI, and METAVIR scores. Treatment eras were divided into 1990–2000 (n = 18), 2001–2010 (n = 31), and 2011–2022 (n = 47). Clearance of jaundice was assessed at three months post-KPE, following established literature benchmarks. Kaplan-Meier curves and Log-Rank tests were used for survival analyses with a median follow-up of 5.1 years (range: 1–10 years). Results: The 10-year native liver survival (NLS) rate was 52.4%, with overall survival (OS) of 69.6%. Preoperative ALBI and APRI scores showed limited prognostic value (p = 0.12 and p = 0.17, respectively). However, postoperative APRI scores exceeding 1.12 at three months significantly predicted poor outcomes (p = 0.00094). METAVIR scores demonstrated poor correlation with long-term outcomes (p = 0.26). Analysis across treatment eras revealed significant improvement, with NLS increasing from 42.1 to 64.8% (p = 0.0029) and OS from 56.3 to 85.2% (p < 0.0001) between 1990 and 2000 and 2011–2022. Among the 52 patients with completed 10-year follow-up, the jaundice clearance rate at three months was 31.2%. Conclusions: While preoperative scoring systems showed limited predictive ability, postoperative APRI scores at three months emerged as a powerful predictor of long-term outcomes in BA patients. Our findings suggest that patients with three-month postoperative APRI scores > 1.12 should receive more intensive monitoring and earlier consideration for transplantation. The significant improvement in outcomes across three decades demonstrates the value of accumulated institutional experience and improved clinical management protocols in this challenging disease. Trial registration: Not applicable.
- 21 May 1999
- Published by Springer Nature in Pediatric Surgery International
- Vol. 15 (3-4) , 217-220
Hydatid disease of the liver in childhood
The records of 100 children with hydatid disease were reviewed retrospectively from 1978 to 1997; 43 were girls and 57 were boys. The mean age was 9.14 years; 61 patients had 124 hepatic cysts. Presenting symptoms were asymptomatic abdominal masses, found masses incidentally during ultrasonography (US), or acute abdomen. Plain X-ray films, US, or computerized tomography (CT) are sufficient for diagnostic evaluation in endemic areas. In the differential diagnosis, laboratory investigations such as the Casoni and Weinberg tests, indirect hemagglutination, eosinophilia, and ELISA were also used. These tests may give negative results, however, in some patients with hydatid disease. The mean follow-up time was 10.5 years (range 1–18 years), the mean duration of hospitalization 7 days. The complication rate was 3.6%. Mortality was 3.27% and occurred after the administration of formaldehyde and hypertonic scolicidal agents. Hydatid disease of the liver can be treated medically in selected patients; conservative surgical approaches that save as much parenchyma as possible, such as partial cystectomy and capitonnage, are indicated in the other cases.
- 21 May 1999
- Published by Springer Nature in Pediatric Surgery International
- Vol. 15 (3-4) , 217-220
Hydatid disease of the liver in childhood
The records of 100 children with hydatid disease were reviewed retrospectively from 1978 to 1997; 43 were girls and 57 were boys. The mean age was 9.14 years; 61 patients had 124 hepatic cysts. Presenting symptoms were asymptomatic abdominal masses, found masses incidentally during ultrasonography (US), or acute abdomen. Plain X-ray films, US, or computerized tomography (CT) are sufficient for diagnostic evaluation in endemic areas. In the differential diagnosis, laboratory investigations such as the Casoni and Weinberg tests, indirect hemagglutination, eosinophilia, and ELISA were also used. These tests may give negative results, however, in some patients with hydatid disease. The mean follow-up time was 10.5 years (range 1–18 years), the mean duration of hospitalization 7 days. The complication rate was 3.6%. Mortality was 3.27% and occurred after the administration of formaldehyde and hypertonic scolicidal agents. Hydatid disease of the liver can be treated medically in selected patients; conservative surgical approaches that save as much parenchyma as possible, such as partial cystectomy and capitonnage, are indicated in the other cases.
- 20 March 1998
- Published by Springer Nature in Pediatric Surgery International
- Vol. 13 (2-3) , 118-120
The effect of an H 2 -receptor antagonist on small-bowel colonization and bacterial translocation in newborn rats
Bacterial translocation (BT) is defined as the passage of enteric bacteria from the gastrointestinal tract to extraintestinal tissues. Bacterial overgrowth is one of the main promoting factors of BT, which is thought to play an important role in the pathogenesis of sepsis and necrotizing enterocolitis. It is believed that small-bowel colonization is established by bacterial spread through the rectum. Gastric acid is also involved in this process. An experimental study was designed for investigating the effect of gastric acid inhibition with the use of an H2-receptor antagonist on intestinal colonization and BT in newborn rats. Animals were divided into two groups: the ranitidine group (n = 20) received ranitidine 10 mg/kg per day intramuscularly for 5 days; the control group (n = 30) received saline solution. Mesenteric lymph node, spleen, liver, stomach, small bowel/cecum, and large bowel specimens were obtained from each rat 5 days later and gram-negative and -positive aerobic bacteria identified by the use of chocolate and Endo agar. It is concluded that: (1) there was a strong correlation between gastric and small-bowel bacterial colonization in the ranitidine group; (2) no correlation between large-and small-bowel colonization could be demonstrated; and (3) BT occurred only in the ranitidine group.
- 20 March 1998
- Published by Springer Nature in Pediatric Surgery International
- Vol. 13 (2-3) , 118-120
The effect of an H 2 -receptor antagonist on small-bowel colonization and bacterial translocation in newborn rats
Bacterial translocation (BT) is defined as the passage of enteric bacteria from the gastrointestinal tract to extraintestinal tissues. Bacterial overgrowth is one of the main promoting factors of BT, which is thought to play an important role in the pathogenesis of sepsis and necrotizing enterocolitis. It is believed that small-bowel colonization is established by bacterial spread through the rectum. Gastric acid is also involved in this process. An experimental study was designed for investigating the effect of gastric acid inhibition with the use of an H2-receptor antagonist on intestinal colonization and BT in newborn rats. Animals were divided into two groups: the ranitidine group (n = 20) received ranitidine 10 mg/kg per day intramuscularly for 5 days; the control group (n = 30) received saline solution. Mesenteric lymph node, spleen, liver, stomach, small bowel/cecum, and large bowel specimens were obtained from each rat 5 days later and gram-negative and -positive aerobic bacteria identified by the use of chocolate and Endo agar. It is concluded that: (1) there was a strong correlation between gastric and small-bowel bacterial colonization in the ranitidine group; (2) no correlation between large-and small-bowel colonization could be demonstrated; and (3) BT occurred only in the ranitidine group.
- 1 January 1991
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 26 (1) , 32-36
Ultrasonographic findings and management of intrahepatic biliary tract abnormalities after portoenterostomy
- 1 January 1991
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 26 (1) , 32-36
Ultrasonographic findings and management of intrahepatic biliary tract abnormalities after portoenterostomy